Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

9.31
Delayed Data
As of 11:06am ET
 -0.01 / -0.11%
Today’s Change
6.10
Today|||52-Week Range
13.80
+10.57%
Year-to-Date

Today’s Trading

Previous close9.32
Today’s open9.35
Day’s range9.19 - 9.35
Volume8,454
Average volume (3 months)53,714
Market cap$172.7M
Dividend yield42.31%
Data as of 11:06am ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-450.00%
Earnings growth (this year)-65.91%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.70

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.03+0.27%
CTSOCytosorbents Corp0.000.00%
CDXCChromadex Corp-0.03-1.04%
NATRNatures Sunshine Pro...+0.23+1.79%
Data as of 11:33am ET, 01/20/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$23.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Director, Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts


Search for Jobs